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Abstract: Emerging Fusarium and Alternaria mycotoxins gain more and more interest due to their
frequent contamination of food and feed, although in vivo toxicity and toxicokinetic data are limited.
Whereas the Fusarium mycotoxins beauvericin, moniliformin and enniatins particularly contaminate
grain and grain-based products, Alternaria mycotoxins are also detected in fruits, vegetables and
wines. Although contamination levels are usually low (µg/kg range), higher contamination levels
of enniatins and tenuazonic acid may occasionally occur. In vitro studies suggest genotoxic effects
of enniatins A, A1 and B1, beauvericin, moniliformin, alternariol, alternariol monomethyl ether,
altertoxins and stemphyltoxin-III. Furthermore, in vitro studies suggest immunomodulating effects
of most emerging toxins and a reproductive health hazard of alternariol, beauvericin and enniatin
B. More in vivo toxicity data on the individual and combined effects of these contaminants on
reproductive and immune system in both humans and animals is needed to update the risk evaluation
by the European Food Safety Authority. Taking into account new occurrence data for tenuazonic
acid, the complete oral bioavailability, the low total body clearance in pigs and broiler chickens and
the limited toxicity data, a health risk cannot be completely excluded. Besides, some less known
Alternaria toxins, especially the genotoxic altertoxins and stemphyltoxin III, should be incorporated
in risk evaluation as well.
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1. Introduction
Mycotoxins are low-molecular-weight secondary fungal metabolites that can contaminate various
food and feed commodities, including but not limited to grain and grain-based products, vegetables,
fruits and fruit juices, oil seeds and oils, spices, coffee and wine [1,2]. The continuous development of
liquid chromatography coupled to mass spectrometric methods makes it possible to analyze an almost
non-exhaustive list of mycotoxins in a variety of food and feed matrices [3,4]. These multi-mycotoxin
screenings revealed a high prevalence of so called “emerging” mycotoxins. In feed for example, the
Fusarium mycotoxins beauvericin (BEA), enniatins (ENNs) and moniliformin (MON) were detected
in 98%, 96% and 76% of the feed and feed ingredient samples (n = 83), respectively. Eighty-two
percent, 80% and 65% of the samples analyzed between 2010 and 2012 were contaminated with the
Alternaria mycotoxins alternariol monomethyl ether (AME), alternariol (AOH) and tenuazonic acid
(TeA), respectively [4]. Although these mycotoxins are frequently detected, no legislation or guideline is
available and the in vivo toxicity data is limited. In vitro studies suggest genotoxic effects of BEA, ENN
A, A1, B1, MON, AOH, AME, altertoxin-II (ATX-II) and stemphyltoxin-III (STTX-III) [5–10]. Besides,
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MON and TeA cause severe toxicity in animals, with MON mainly affecting the heart and TeA causing
hemorrhages [11–14]. Therefore, these frequently detected food and feed contaminants could pose a
health risk for humans and animals. In 2014 and 2011, the European Food Safety Authority (EFSA)
disclosed some knowledge gaps regarding the occurrence, toxicity and toxicokinetics of BEA, ENNs
and Alternaria toxins. Since then, new studies focusing on occurrence, toxicokinetics and metabolism
of these emerging mycotoxins have been published [15–23]. Therefore, the objective of this review
is to give an updated overview of the occurrence in food and feed, in vitro and in vivo toxicity and
toxicokinetics of BEA, ENNs, MON and the Alternaria mycotoxins. In addition, remaining knowledge
and research gaps in this field were identified. For an overview of other emerging mycotoxins, the
authors would like to refer to the work of Gruber-Dorninger et al. (2016) [24].
2. Beauvericin and Enniatins
In the search for new antibiotics, BEA was isolated for the first time from Beauveria bassiana as
early as in 1969 [25]. BEA and ENNs are cyclic depsipeptides produced by a wide variety of Fusarium
fungi, including but not limited to F. acuminatum, F. avenaceum, F. oxysporum, F. poae, F. sporotrichioides,
F. sambucinum and F. tricinctum [26–30]. Most frequently detected mycotoxins are BEA, ENN A, A1, B
and B1 (Figure 1).
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Figure 1. Chemical structure of beauvericin, enniatin A, A1, B and B1. Beauvericin (BEA), R1 = R2 = 
R3 = phenylmethyl; Enniatin A (ENN A), R1 = R2 = R3 = –CH(CH3)CH2CH3; Enniatin A1 (ENN A1), 
R1 = R2 = –CH(CH3)CH2CH3, R3 = –CH(CH3)2; Enniatin B (ENN B), R1 = R2 = R3 = –CH(CH3)2; Enniatin 
B1 (ENN B1), R1 = R2 = –CH(CH3)2, R3 = –CH(CH3)CH2CH3. 
2.1. Occurrence of Beauvericin and Enniatins in Food and Feed 
BEA and ENNs can contaminate a variety of foodstuffs (Table 1). Grain‐based food products are 
the most important contributors to the acute and chronic dietary exposure [16]. BEA contaminated 
the majority  of  Scandinavian  cereals,  including wheat,  oats,  barley  and  rye.  Prevalence  ranged 
between  12%  and  100%.  Mostly,  contamination  levels  were  below  100  μg/kg.  The  highest 
concentration  detected  was  220  μg/kg  in  barley  [17,31,32].  Compared  to  Scandinavian  cereals, 
Moroccan samples contained much higher BEA levels, with a maximum contamination level of 26,300 
μg/kg in rice. Moroccan breakfast cereals and couscous seemed not frequently contaminated (0–2.9%), 
but Moroccan  rice was highly contaminated  (76%). However,  it should be noted  that  the  limit of 
quantification (LOQ) in the studies of Mahnine et al. (2011) and Sifou et al. (2011) was rather high 
(500 μg/kg), which at least partly could explain the lower incidence of BEA in Moroccan cereals. The 
differences in LOQ could be attributed to the fact that both Mahnine et al. (2011) and Sifou et al. (2011) 
Figure 1. Chemical structure of beauvericin, enniatin A, A1, B and B1. Beauvericin (BEA), R1 = R2
= R3 = phenylmethyl; Enniatin A (ENN A), R1 = R2 = R3 = –CH(CH3)CH2CH3; Enniatin A1 (ENN
A1), R1 = R2 = –CH(CH3)CH2CH3, R3 = –CH(CH3)2; Enniatin B (ENN B), R1 = R2 = R3 = –CH(CH3)2;
Enniatin B1 (ENN B1), R1 = R2 = –CH(CH3)2, R3 = –CH(CH3)CH2CH3.
2.1. Occurrence of Beauvericin and Enniatins in Food and Feed
BEA and ENNs can contaminate a variety of foodstuffs (Table 1). Grain-based food products are
the most important contributors to the acute and chronic dietary exposure [16]. BEA contaminated the
majority of Scandinavian cereals, including wheat, oats, barley and rye. Prevalence ranged between
12% and 100%. Mostly, contamination levels were below 100 µg/kg. The highest concentration
detected was 220 µg/kg in barley [17,31,32]. Compared to Scandinavian cereals, Moroccan samples
contained much higher BEA levels, with a maximum contamination level of 26,300 µg/kg in rice.
Moroccan breakfast cereals and couscous seemed not frequently contaminated (0–2.9%), but Moroccan
rice was highly contaminated (76%). However, it should be noted that the limit of quantification (LOQ)
in the studies of Mahnine et al. (2011) and Sifou et al. (2011) was rather high (500 µg/kg), which at
least partly could explain the lower incidence of BEA in Moroccan cereals. The differences in LOQ
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could be attributed to the fact that both Mahnine et al. (2011) and Sifou et al. (2011) used LC-diode
array detection (DAD) to determine BEA, whereas other authors used LC-MS [17,31–37].
Regarding ENNs, almost all Scandinavian cereal samples were contaminated, with a high
prevalence (range 96% and 100%). Contamination levels were usually in the µg/kg range (median
concentrations 41–569 µg/kg), but could occasionally reach the lower mg/kg range. The maximum
concentration was about 14,850 µg/kg in a barley sample. Scandinavian results were reported as
the sum of different ENN analogues, ENN A, A1, B, B1, B2 and B3, respectively or the analogue
was not specified in the presented results [17,31,32]. Similar to BEA, contamination levels for ENNs
were higher in Moroccan cereals. Maximum concentrations of ENN B1 (795,000 µg/kg), ENN A1
(688,000 µg/kg), ENN A (119,500 µg/kg), and ENN B (81,100 µg/kg) were found in wheat, muesli,
rice and oats, respectively [33,34]. In contrast, Moroccan couscous was not contaminated with BEA
(n = 98, LOD = 1 µg/kg) and ENN concentrations were mostly lower than 100 µg/kg [35].
Concerning feed, the prevalence of BEA ranged between 50% and 98%, and the observed
maximum concentrations were up to 2326 µg/kg. Regarding ENNs, feed contamination levels ranged
between <0.1–1745, <0.15–2216, <0.3–1514 and <0.2–2690 µg/kg, for ENN A, A1, B and B1, respectively
(Table 1) [4,38–40].
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Table 1. Occurrence of emerging Fusarium and Alternaria mycotoxins in food and feed.
Commodity Mycotoxin Total # SamplesAnalyzed
Prevalence Range
(%)
Concentration Range
(µg/kg)
Origin of Sample
with Maximum
Concentration
Reference
Cereals (unprocessed) a BEA 482 12–100 <10–327 Sweden [17,31,32]
ENNs b 482 96–100 Finland [17,31,32]
MON 590 0.88–100 <15–2606 Italy [17,31,32,41]
AOH 1582 2.4–47 0.75–832 Germany [42–46]
AME 1582 3.1–7.1 0.3–905 Germany [42–46]
TeA 1526 15–68 0.1–4224 Germany [42–44]
ALT 1106 2.63–7.1 6–196.6 Germany [42,45]
ATX-I 42 2.4 43 South Africa [45]
TEN 370 77 0.4–258.6 China [44]
Rice BEA 70 75.7 3800–26,300 Morocco [34]
ENN A 70 22.8 8400–119,500 Morocco [34]
ENN A1 70 5.7 56,200–448,700 Morocco [34]
ENN B 70 30 4400–26,200 Morocco [34]
ENN B1 70 24.3 3600–23,700 Morocco [34]
Cereal products BEA 354 0–17.5 0.1–10,600 Morocco [33,35–37]
ENN A 354 2.9–77 0.5–29,700 Morocco [33,35–37]
ENN A1 354 30–100 0.25–688,000 Morocco [33,35–37]
ENN B 354 13.2–100 0.5–81,100 Morocco [33,35–37]
ENN B1 354 17.6–100 0.5–795,000 Morocco [33,35–37]
AOH 83 31–89 8–121 Italy [18,36]
AME 83 26–89 <0.4–48 Italy [18,36]
TeA 9 100 <100–210 Germany [18]
TEN 9 100 <1.6–12 Germany [18]
Tomato products c AOH 187 28–70.6 <2–41.6 Belgium [18,19,46,47]
AME 187 20–79 <0.9–7.8 The Netherlands [18,19,46,47]
TeA 187 40–100 <5–462 The Netherlands [18,19,46,47]
ALT 83 32–56 6.1–62.0 Belgium [19]
TEN 117 21–64 <3.9–8.9 Belgium [18,19]
AOH-3-sulfate 83 11–26 2.6–8.7 Belgium [19]
AME-3-sulfate 83 32–78 1.7–9.9 Belgium [19]
Fruit juices d AOH 101 15–100 <0.2–16 Germany [18,48]
AME 101 25–100 <0.13–4.9 Germany [18,48]
TeA 101 8–100 <1.1–250 Germany [18,48]
ALT 101 4.3–100 1.18–18.4 Germany [18,48]
TEN 101 22–100 <0.5–10.27 Germany [18,48]
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Table 1. Cont.
Commodity Mycotoxin Total # SamplesAnalyzed
Prevalence Range
(%)
Concentration Range
(µg/kg)
Origin of Sample
with Maximum
Concentration
Reference
altenuic acid 78 100 2.71 Germany [48]
altenuisol 78 8–50 <0.74–5.58 Germany [48]
Infant food e TeA 40 100 0.8–1200 Germany [49]
Wines AOH 30 20–93 0.65–11 The Netherland [46,48]
AME 25 93 0.8–1.45 Germany [48]
TeA 25 60–100 <1–60 Germany [48]
TEN 25 71 1.01–1.47 Germany [48]
altenuic acid 25 21–64 <1–6.1 Germany [48]
altenuisol 25 55–71 <0.74–2.91 Germany [48]
Dried figs and olives AOH 14 7 8.7 The Netherlands [47]
TeA 19 10–100 5.3–2345 The Netherlands [46,47]
Vegetable oil AOH 19 47 ≤6 Germany [18]
AME 19 84 <1.1–14 Germany [18]
TeA 19 21 15 Germany [18]
TEN 19 47 <6.6–11 Germany [18]
Sunflower seeds and oils AOH 35 10–55 <4.9–39 Germany [18,47]
AME 35 9–64 <0.5–17 The Netherlands [18,47]
TeA 40 80–100 <5–1350 The Netherlands [18,46,47]
ALT 11 9 <14 Germany [18]
ATX-I 11 9 <45 Germany [18]
TEN 16 20–91 <3.7–800 Germany [18,46]
Feed BEA 1345 50–98 <2–2326 not specified [4,38–40]
ENN A 1315 0–87 <0.1–1745 not specified [4,39,40]
ENN A1 1315 12–95 <0.15–2216 not specified [4,39,40]
ENN B 1414 28–92 <0.3–1514 not specified [4,39,40,50]
ENN B1 1315 12–92 <0.2–1846 not specified [4,39,40]
MON 1315 3–79 <2–12,236 not specified [4,39,40]
AOH 264 0–80 17–221 not specified [4,50,51]
AME 264 1.5–82 <6–733 not specified [4,50,51]
TeA 83 65 not specified-1983 not specified [4]
a Including wheat, oats, barley and rye; b Sum of different ENNs or not specified; c Including tomato sauce, paste, pieces, concentrate, pieces and ketchup; d Including apple, apricot,
carrot, citrus, currant, grape, grapefruit, multi fruit, orange, sour cherry and vitaminized (ACE) juice; e Including tea infusions, puree infant food and cereals.
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2.2. Toxicity of Beauvericin and Enniatins
2.2.1. In Vitro Toxicity
The cytotoxic effects of BEA and ENNs have been demonstrated in a variety of cell cultures
(Table 2) [5,6,52–56]. The mechanism of toxicity is considered to be related to their ionophoric properties.
BEA and ENNs can insert into the cell membrane, forming cation-selective pores and influencing
cellular ionic homeostasis. Increased intracellular Ca2+ can trigger cytochrome C release, which
consequently induces an increased caspase-3 activity, resulting in apoptosis. Furthermore, increased
intracellular Ca2+ can also trigger necrosis [5,6,54,57,58]. Besides, BEA and ENNs exert their cytotoxic
effect through stimulating the production of reactive oxygen species (ROS) resulting in induction of
lipid peroxidation (LPO) and glutathione depletion in Caco-2 cells [5,6,58]. Prosperini et al. (2013)
demonstrated that ENN A and A1 were more cytotoxic compared to ENN B1 and BEA, while ENN B
had the lowest cytotoxic effect in Caco-2 cells. On the other hand, IPEC-J2 cells were more sensitive
to ENN B, followed by BEA, ENN B1, ENN A and ENN A1. In Caco-2 cells, ENN A, A1 and B1
induced DNA damage, resulting in a cell cycle arrest at the G2/M phase at concentrations between 1.5
µM and 3.0 µM. ENN B was not genotoxic in Caco-2 cells. BEA caused cell cycle arrest in the G2/M
phase and S phase, presumably as a result of the cellular redox imbalance and at higher concentrations
(12 µM), BEA caused DNA damage in Caco-2 cells. Above, 2.5–10 µM BEA promoted chromosome
aberrations, increased the frequency of sister-chromatid exchanges and induced micronuclei in human
lymphocytes (Table 2) [5–7,59].
The neurotoxic and myotoxic effects of BEA were demonstrated in a mouse hemidiaphragm
preparation. At low concentrations (5 µM), BEA depressed acetylcholine release presynaptically, but at
higher concentrations (7.5 and 10 µM), BEA had a direct effect on skeletal muscle fibers, resulting in
contractures [60].
Additionally, limited in vitro studies also suggest a toxic effect of BEA and ENNs on the
reproductive system (Table 2). BEA impaired the development of cultured porcine oocytes and
early embryos. Exposure to BEA resulted in a decreased progesterone synthesis in cumulus cells,
reduced MDR1 activity as a consequence of ATP depletion in zygotes and decreased mitochondrial
activity in early embryos [61]. Besides, BEA inhibited estradiol and progesterone synthesis in bovine
granulosa cells by suppressing CYP19A1 and CYP11A1 gene expression [62]. ENN B also reduced
progesterone, testosterone and cortisol secretion in human adrenocortical carcinoma cells (H295R) and
modulated the expression of genes involved in steroidogenesis [63].
Furthermore, BEA and ENNs exert immunomodulating effects (Table 2). Ficheux et al. (2013)
demonstrated that BEA and ENN B increase IL-10 secretion and affect the initiation of the adaptive
immune response by interfering with dendritic cell migration. Moreover, endocytosis by macrophages
was decreased after exposure to BEA and ENN B [53]. Besides, ENNs and BEA could also affect
health by antimicrobial effects on both pathogenic and probiotic microorganisms. BEA inhibited
the growth of pathogenic bacteria, such as Escherichia coli, Enterococcus faecium, Salmonella enterica,
Shigella dysenteriae, Listeria monocytogenes, Yersinia enterocolitica, Clostridium perfringens and Pseudomonas
aeruginosa [64]. On the other hand, ENN A, A1 and B1 could also inhibit the growth of probiotic
microorganisms. Roig et al. (2014) demonstrated the growth inhibition of Streptococcus thermophilus
and different strains of the genus Bifidobacterium and Lactobacillus by ENN A1 and ENN B1, while ENN
A inhibited Saccharomyces cerevisiae. No impact of ENN B was observed on the growth of different
probiotic microorganisms [65]. Further studies on the antimicrobial effects of BEA and ENNs are
limited, however, indicating a potential impact on the intestinal microbiota.
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Table 2. In vitro toxicity of emerging Fusarium and Alternaria mycotoxins.
Cell Line Mycotoxin Exposure Time Exposure Dose (µM) Effect Reference
Caco-2 a BEA 0 min 1.5 ROS b generation [5,6,56,66,67]
24–72 h IC50: 20.6–3.2 µM (MTT c); IC50: 8.8–1.9 µM (NR d)
24–72 h 1.5–3.0
LPO e, ↓ GSH, ↑ GSSG, loss of mitochondrial
membrane potential, cell cycle arrest in S and G2/M,
apoptosis and necrosis
24 h 12 DNA damage
ENN A <1 h 1.5–3.0 ROS generation
24–72 h IC50: 9.3–0.46 µM
24–72 h 1.5–3.0
LPO, loss of mitochondrial membrane potential, cell
cycle arrest in SubG0/G1 and (Sub)G2/M, DNA
damage, apoptosis and necrosis
ENN A1 10 min 1.5 ROS generation
24–72 h IC50: 12.3–0.46 µM
24–72 h 1.5–3.0
LPO, loss of mitochondrial membrane potential, DNA
damage, cell cycle arrest in (Sub)G0/G1 and G2/M,
apoptosis, necrosis
ENN B 10 min 3.0 ROS generation
48–72 h IC50: 10.7–1.4 µM
24–72 h 1.5–3.0
LPO, loss of mitochondrial membrane potential, cell
cycle arrest in (Sub)G0/G1, and G2/M, apoptosis,
necrosis
ENN B1 5–10 min 1.5–3.0 ROS generation
48–72 h IC50: 10.8–0.8 µM
24–74 h 1.5–3.0
LPO, loss of mitochondrial membrane potential, DNA
damage, cell cycle arrest in (Sub) G0/G1, G2/M and S,
apoptosis, necrosis
MON 72 h IC50: 30.9 µg/mL
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Table 2. Cont.
Cell Line Mycotoxin Exposure Time Exposure Dose (µM) Effect Reference
AOH 24 h 15–30 changes in MMP
f, ↓ G1 phase, ↑ S and G2/M phase,
apoptosis, necrosis
HT-29 g ENN A 24–48 h IC50: 9.3–8.2 µM [56]
ENN A1 24–48 h IC50: 9.1–1.4 µM
ENN B 24–48 h IC50: ≥2.8 µM
ENN B1 24–48 h IC50: 16.8–3.7 µM
HCT116 g AOH
IC50, 24h: 65 µM
↓ early apoptotic and late apoptotic/necrotic cells,
ROS generation
PTP h-dependent MMP
caspase-cascade activation, activation of p53 protein
expression
[68,69]
AME
IC50, 24h: 120 µM
apoptotic cell death, PTP-opening, induction of MMP,
cytochrome c release
caspase-cascade activation, ↑ p53 protein, ROS
generation
IPEC-J2 i BEA 24–72 h 5–10 TEER
j reduction (between −59% and −80%), no
reduction of cell viability
[59]
ENN A 72 h 5 TEER reduction (−70%), no reduction of cell viability
ENN A1 24–72 h 10 TEER reduction (between −29% and −74%), noreduction of cell viability
ENN B 48–72 h 2.5 TEER reduction (between −55% and −68%), noreduction of cell viability
ENN B1 48–72 h 5 TEER reduction (between −44% and −58%), noreduction of cell viability
ENN
combinations 1.5 additive effect on TEER reduction
MON 72 h 5–10 no effect on TEER or viability [59]
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Table 2. Cont.
Cell Line Mycotoxin Exposure Time Exposure Dose (µM) Effect Reference
Hep-G2 k ENN A 24–48 h IC50: 26.2–11.4 µM [56,66]
ENN A1 24–48 h IC50: 11.6–2.6 µM
ENN B 24–48 h IC50: >30 µM
ENN B1 24–48 h IC50: 24.3–8.5 µM
MON 48–72 h IC50: 39.5–24.1 µg/mL
H295R l ENN B 72 h 10–100
↓ viability by 37%, ↑ S-phase, ↓ G0/G1phase, ↑
apoptosis
↓ HMGR, STAR, CYP11A, HSD3B2, CYP17A1
↑ CYP1A1, MC2R, NR0B1, CYP21A2, CYP11B1,
CYP19
↓ progesterone, testosterone and cortisol; estradiol
unaffected
[63,70,71]
AOH 3.87
no influence on viability
↑ 7 proteins (FDX1, HSD3B, CYP21A2, SCAMP3,
SOAT1, ARF6, RRP15)
↓ 15 proteins (ACTBL2, NUCKS1, EIF2B5, COX2,
CRMP1, ABHD14A-ACY1, ATP5J, ACSF2, HN1,
ETHE1, HIST1H1E, ACBD5, NPC1, NR5A1, TOMM7)
upregulation mRNA for CYP21A2 and HSD3B
↑ G0/G1 and ↑ G2/M phase
H29R l AOH
no effect on testosterone and cortisol levels
↑ progesterone and estradiol levels
↓ NR0B1 gene
↑ CYP1A1, MC2R, HSD3B2, CYP17, CYP21, CYP11B2,
CYP19
[72]
neonatal Leydig
cells ENN B 10–100
↓ viability by 20%, ↓ estradiol in unstimulated cells
↓ estradiol and testosterone in LH stimulated cells,
probably due to cytotoxicity
[63]
human breast
adenocarcinoma
RGA cell line
AOH
agonistic estrogen response, relative estrogenic
potential: 0.0004% and equivalent estrogenic quantity
of 17β-estradiol: 2.9 fg/mL
[72]
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Table 2. Cont.
Cell Line Mycotoxin Exposure Time Exposure Dose (µM) Effect Reference
cell free buffer AOH
binding affinity to ERα: 10,000× lower compared to
17β-estradiol
binding affinity to ERβ: 2500× lower compared to
17β-estradiol
similar EC50
[73]
Ishikawa human
endometrial
adenocarcinoma
cell line
AOH 2.5–10
↑ alkaline phosphatase mRNA and activity
↓ G1 phase and ↑ S and G2/M phase
↓ cell number due to inhibition of proliferation
[73]
porcine oocytes
and embryos BEA >0.5
↓ rate of development of maturing oocyte and 2–4 cell
stage embryo, activated oocytes and 2–4 cell stage
embryos more sensitive than maturing oocytes,
compromised cytoplasmic maturation and abnormal
meiosis in oocytes, ↓ cumulus viability and
progesterone synthesis, cumulus cells control
intracellular BEA through MDR1 activity, in oocytes
mitochondrial function was altered, altered gene
expression in cumulus cells and oocytes, altered
MDR1 activity in activated oocytes, ↓ viability embryo
[61]
pig granulosa
cells AOH 0.8–1.6
↓ cell viability, ↓ progesterone levels, ↓ P450scc
↓ α-tubulin, actin and EIF4a [71]
AME 0.8–1.6 ↓ cell viability, ↓ progesterone levels, ↓ P450scc
TeA 6.4–100 no influence on viabilityno influence on progesterone concentrations
bovine
granulosa cells BEA 3
↓ estradiol and progesterone production
↓ CYP11A1 and CYP19A1 mRNA [62]
6–10 ↓ (fetal calf serum-induced) proliferation
CHO-K1 m BEA 24–72 h
IC50: 10.7–2.2 µM
combination of BEA + PAT n, BEA + STG o, BEA +
PAT + STG: synergistic effect at low (IC < 1), additive
effect at higher (IC 0.6–5.9) doses
[52,66,74]
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Table 2. Cont.
Cell Line Mycotoxin Exposure Time Exposure Dose (µM) Effect Reference
ENN A 24–72 h >7.5–2.83 µM
ENN A1 24–72 h 8.8–1.65 µM
ENN B 24–72 h 11.0–2.44 µM
ENN B1 24–72 h 4.53–2.47 µM
ENN
combinations 24 h
additive effects: A + B1, A1 + B, B + B1
synergistic effects: A + A1, A + B, A1 + B1, A1 + B1, A
+ A1 + B, A + A1 + B1, A1 + B + B1 (higher
concentrations)
antagonistic effects: A + A1 + B1, A1 + B +B1 (lower
concentrations)
MON IC50: >100 µg/mL
THP-1 p
monocyte AOH 24–48 h 7.5–15 cell cycle arrest in S- and G2/M-phase [55]
↓ CD14 and CD11b upregulation during macrophage
differentiation
↓ downregulation of CD71 during macrophage
differentiation,
↓ TNF-α secretion due to ↓ gene expression
+DON: additive effect
+ZEA: synergistic effect on macrophage differentiation
CCRF-CEM q BEA 24 h 1 cytotoxicity, apoptosis [54]
human
lymphocytes MON 48 h
10–25
15–25
chromosome breaks, chromatid breaks and exchanges,
polyploidy,
increase in sister chromatid exchanges and
micronuclei frequency
all effects were dose-dependent
[8]
human
immature
dendritic cells
BEA IC50: 1.0 µM [53]
ENN B IC50: 1.6 µM
MON 80 20% mortality, ↓ endocytosis, ↓ CD1a expression
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Table 2. Cont.
Cell Line Mycotoxin Exposure Time Exposure Dose (µM) Effect Reference
human mature
dendritic cells
BEA IC50: 2.9 µM, ↓ CCR7 expression, ↑ IL-10concentration [53]
ENN B IC50: 2.6 µM, ↓ CD80, CD86 and CCR7 expression, ↑IL-10
MON 80 20% mortality
human
macrophages BEA ≥0.5 IC50: 2.5 µM, ↓ endocytosis [53,75]
ENN B IC50: 2.5 µM, ↓ endocytosis, ↑ CD71
MON ↓ endocytosis, ↓ CD71, ↓ HLA-DR
AOH 24 h 30
changed morphology: from round to elongated with
dendrite-like protrusions
↑ CD83 and CD86
↓ HLA-DR and CD68
↑ secretion of TNFα and IL-6
↓ endocytosis and ↓ autophagy
double DNA strand breaks
RAW 2654.7
mouse
macrophage
AOH 24–48 h 30
changed morphology: from round to flattened,
star-shaped or elongated spindle-shaped cells
micronuclei, polyploidy, ↑ CD86, CD80, MHCII (T cell
activation), ↑ CD11b
↑mRNA of TNFα and IL-6, but only ↑ TNFα
secretion, ↑ endocytosis
[75]
mouse
hemidiaphragm
preparation
BEA 5
inhibition (in) directly elicited tetanic muscle
contraction; inhibition nerve-evoked and directly
elicited muscle twitches, reduction amplitude and
frequency of miniature endplate potentials
[60]
1 h 7.5 inhibition directly elicited twitches, inductioncontracture, decrease resting membrane potential
1 h 10
complete block of (in) directly elicited isometric
muscle contraction, amplitude reduction of directly
elicited muscle twitch, decrease resting membrane
potential
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Table 2. Cont.
Cell Line Mycotoxin Exposure Time Exposure Dose (µM) Effect Reference
C5-O r MON 72 h IC50: 34.2 µg/mL [66]
V79 s MON 72 h IC50: >100 µg/mL [62,66,73]
AOH 5–50 induction of micronuclei cell cycle arrest in G2 and Sphase
↓ decrease; ↑ increase; a human adenocarcinoma colon cells; b reactive oxygen species; c tetrazolium salt reduction assay; d Neutral Red assay; e lipid peroxidation; f mitochondrial
membrane permeabilization; g human colon carcinoma cells; h permeability transition pore; i intestinal porcine epithelial cells from the jejunum; j transepithelial electrical resistance; k
human hepatocellular carcinoma cells; l human adrenocortical carcinoma cells; m Chinese hamster ovary cells; n patulin; o sterigmatocystin; p human acute monocyte leukemia cell line; q
human leukemia cells; r Balb/c mice keratinocyte cells; s Chinese hamster lung fibroblast.
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2.2.2. In Vivo Toxicity
The in vitro observed immunomodulating effects of BEA and ENNs have been confirmed in
rodents. ENN A modulated surface antigen expression of peripheral blood lymphocytes. The number
of T-helper (CD4+) cells increased, while cytotoxic T-cells (CD8+) decreased in Wistar rats fed an
ENN A contaminated feed (465 mg/kg) for 28 days [76]. BEA decreased serum levels of tumor
necrosis factor (TNF-)α and interferon (IFN-)γ, and induced apoptosis of activated T-cells of mice
with experimental colitis after intraperitoneal (ip) administration (2–4 mg/kg) [77]. Fusafungine, a
nose and mouth spray consisting of a mixture of ENNs, was used to treat upper airway infections.
Mice exposed to fusafungine oral spray, showed low-grade dysplasia, congestion and edema on the
tongue, hyperplasia of the cheek mucosa and low-grade dysplasia of the superficial epithelium [78,79].
Recently, the European Medicines Agency (EMA) has revoked the authorization of fusafungine sprays,
since the benefits do not outweigh the risks, especially the risk of serious allergic reactions [79]. On
the other hand, a daily intake of 20.91 mg ENN A/kg bw/day during 28 days did not cause any
adverse effects in Wistar rat. The ENN A contaminated diet was obtained through infection with
F. tricinctum [80]. However, the EFSA CONTAM Panel concluded that the control and contaminated
feed were not comparable due to fungal growth and that there were insufficient details on the detection
methods used and on the occurrence of other mycotoxins in the feed to draw conclusions [16].
In vivo toxicity data of BEA and ENNs in livestock and companion animals is limited to poultry.
Broiler chickens and laying hens were fed a multi-mycotoxin contaminated diet containing DON
(1710–2228 µg/kg), HT-2 (488–606 µg/kg), T2-toxin (367–343 µg/kg), ZEN (753–820 µg/kg), 3-ADON
(41–66 µg/kg), 15-ADON (91–227 µg/kg), ENN A (28 µg/kg), ENN A1 (491–440 µg/kg), ENN B
(12,716–11,233 µg/kg), ENN B1 (4057–3599 µg/kg) and BEA (10,313–8926 µg/kg) for 14 days. No
impact on animal performances, such as growth, feed uptake and egg production was observed [81].
Feeding a multi-mycotoxin contaminated diet containing up to 2.7 mg/kg MON and up to
12 mg/kg BEA showed no significant effects on growth or carcass traits of broiler chickens. No
residues were detected in the carcass and organs. However, no details on the analytical methods used
to determine the concentration of the mycotoxins in the feed, carcass and organs were described. Since
no LOQ was reported, no conclusions could be drawn regarding tissue residues. Likewise, growth and
slaughter performance were not affected in broilers and turkeys fed a multi-mycotoxin contaminated
diet containing both MON and BEA. Contamination levels were as high as 0.5 mg/kg MON and
0.8 mg/kg BEA in broiler feed, and 3.0 mg/kg MON and 2.48 mg/kg BEA in turkey feed [16,82].
The EFSA Panel on Contaminants in the Food Chain (CONTAM) identified
no-observed-adverse-effect levels (NOAELs) for BEA for broiler chickens (1220 µg/kg bw/day),
laying hens (536 µg/kg bw/day) and turkeys (136 µg/kg bw/day). The identified NOAELs for ENN
B and B1 were 763 and 244 µg/kg bw/day for broiler chickens and 674 and 216 µg/kg bw/day for
laying hens [16]. However, a proper risk assessment of chronic toxicity in livestock other than poultry
and in companion animals is impossible due to the lack of LOAELs and NOAELs. Furthermore, the
EFSA CONTAM panel concluded that the lack of toxicity data precludes a risk assessment for dietary
exposure of humans to BEA and ENNs [16].
2.3. Toxicokinetics of Beauvericin and Enniatins
Besides exposure and toxicity data, knowledge of toxicokinetics is indispensable for a proper risk
assessment, since oral bioavailability, rate of absorption, (pre-)systemic biotransformation, distribution
and excretion influence the internal dose of a compound [83]. Toxicokinetic analysis demonstrated the
high absolute oral bioavailability (F = 90.9%) of ENN B1 in pigs [20]. In contrast, ENN B1 and ENN B
were poorly absorbed after oral administration to broiler chickens, with an F of 5% and 11% for ENN B1
and ENN B, respectively [21]. Both total body clearance (Cl) and volume of distribution (Vd) of ENN
B1 were higher in broiler chickens compared to pigs. The Cl of ENN B1 after iv administration was 6.6
L/h/kg and 1.91 L/h/kg in broiler chickens and pigs, respectively. The Vd of ENN B1 was 25 L/kg
in broiler chickens. In pigs, the toxicokinetics fitted a two-compartmental model with a Vd of the
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central and peripheral compartment of 0.57 and 0.69 L/kg, respectively. The low oral bioavailability
and rather high clearance of ENN B and B1 in chickens is in accordance with the EFSA statement that
chronic and acute adverse health effects associated with BEA and ENNs in poultry are unlikely [16,21].
Remarkable species differences in oral bioavailability and toxicokinetic parameters could be
attributed to differences in biotransformation. Hydroxylated and carboxylated metabolites of ENN B
and B1 have been identified in plasma of poultry and pigs. Additionally, carbonylated metabolites of
ENN B1 have been detected in pig plasma. Metabolite/ENN B1 ratios were higher after oral, compared
to intravenous administration, indicating presystemic metabolism of ENN B1 in pigs. Presystemic
metabolism could not be distinguished from systemic metabolism in broiler chickens, due to the
low parent and metabolite plasma levels after oral administration [21,23,84]. Besides presystemic
metabolism, elimination can also occur through efflux into the gut lumen via ATP-binding cassette
(ABC) transporters. The major ABC transporters are P-glycoprotein (P-gp, multidrug resistance protein
1, MDR 1), multidrug resistance-associated protein 2 (MRP 2) and breast cancer resistance protein
(BCRP) [85,86]. Induction or inhibition of ABC transporters may not only affect oral bioavailability and
absorption, but the entire kinetic profile of toxins and drugs, mainly through their effect on hepatic
and renal Cl and Vd since they are located in these organs as well [87,88]. In vitro studies using
human cell lines suggest that ABC transporters may play an important role in the absorption of ENNs
and BEA, and consequently influencing their oral bioavailability. Ivanova et al. (2010) suggested
that P-gp, MRP 2 and BCRP could be involved in the efflux of ENN B1 into the intestinal lumen.
Besides, overexpression of BCRP and P-gp resulted in a significant resistance towards the cytotoxic
effects of ENNs and BEA in vitro. Above, chronic exposure to stepwise increasing ENN or BEA
concentrations resulted in an upregulation of ABC-transporter proteins and cross-resistance to other
chemotherapeutics in human cell lines [89]. Interestingly, monensin, an ionophoric coccidiostat which
is frequently mixed into poultry feed, can upregulate P-gp expression in the duodenum of broiler
chickens [85,90]. Therefore, it could be investigated whether feed supplementation with monensin
influences the absorption of ENNs and BEA by upregulating the ABC efflux transporters. In addition,
ENNs and BEA reduced the intestinal barrier integrity in vitro. Reduced intestinal barrier integrity
could not only affect bioavailability of xenobiotics, but could also increase the susceptibility to diseases
and reduce performance [59,89]. Taken together, the toxicokinetic behavior of these mycotoxins may be
complex and can vary between both individuals and species, making species- and compound-specific
studies essential.
Data regarding the carry-over of BEA and ENNs in food of animal origin is limited. Finnish
eggs were frequently contaminated with BEA and/or ENNs (56–99.7%). Although levels were low
for most of the egg samples, co-contamination of at least two toxins occurred regularly in the yolk
samples (77%). Both whole egg and yolk samples were most frequently contaminated with ENN B
(93–46% of positive samples) and BEA (7–31% of positive samples), but ENN A and ENN A1 were
only detected in 1% and 2% of the positive yolk samples and were not detected in whole egg samples.
The higher contamination in yolk, compared to whole eggs, could be attributed to the lipophilic nature
of ENNs and BEA [91]. In contrast with the Finnish survey (n = 479 eggs), neither BEA nor ENNs
were detected in commercial eggs (n = 30) or in pig meat (n = 10) obtained from the Belgian market.
In chicken meat samples, only traces of BEA and/or ENNs were detected and ENN B was detected
in 4/16 pig liver samples. It should be noted that the number of samples in the Belgian survey was
limited and no LOQ was reported for the determination of BEA and ENNs in the different Belgian
samples. [16,81]. Callebaut et al. (2011/2012) studied the carry-over of mycotoxins to poultry products
by administrating a multi-mycotoxin contaminated diet to both laying hens and broiler chickens. In
broiler chickens, traces of ENN A and ENN A1 were only detected in meat, however ENN B, ENN B1
and BEA were detected in meat, liver and skin. Carry-over rates for ENN B and B1 were the highest in
skin (0.39% and 0.37%, respectively), followed by liver (0.16% and 0.12%, respectively), thigh muscle
(0.04%) and breast muscle (0.01% and 0.025%, respectively). Carry-over rate for BEA was highest in
liver (1.57%), followed by skin (1.16%) and muscle (0.03%). ENNs and BEA were rapidly eliminated
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from liver and meat, but elimination was slower and incomplete in skin tissue. Regarding eggs, ENN
B, B1 and BEA were detected at 2 to 3 days after the contaminated feed was first administrated and
reached a maximum at day 5. It took up to 10 withdrawal days, during which the hens received a
control diet, to eliminate ENNs and BEA from the eggs. Carry-over rates were highest for BEA (0.44%),
followed by ENN B (0.10%) and ENN B1 (0.05%) [81]. BEA was not detected in milk, sausage, pork or
pig liver [38].
3. Moniliformin
Moniliformin (MON) or 1-hydroxycyclobut-1-ene-3,4 dion (Figure 2) was first identified as a
mycotoxin of F. moniliforme, now referred to as F. verticillioides [92–94]. Besides, MON can also be
produced by F. begoniae, F. denticulatum, F. lactis, F. nisikadoi, F. phyllophilum, F. pseudocircinatum,
F. pseudonygamai, F. ramigenum, F. tricinctum, F. acutatum, F. anthophilum, F. bulbicola, F. concentricum,
F. diaminii, F. fujikuroi, F. napiforme, F. nygamai, F. proliferatum, F. pseudoanthophilum, F. sacchari,
F. subglutinans, F. thapsinum, F. beomiforme, F. oxysporum, F. redolens, F. chlamydosporum, F. arthrosporiodes,
F. avenaceum and F. acuminatum. Above, Penicillium melanoconidium can also produce MON [30,95–97].
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3.1. Occurrence of Moniliformin
Data on the occurrence of MON in food is limited and summarized in Table 1. In European
grain samples, contamination levels ranged between <15–2606 µg/kg and the prevalence ranged
between 0.88–100%. MON levels were usually below 100 µg/kg. The maximum MON concentration
of 2606 µg/kg was detected in Italian maize. However, a relatively high concentration of MON
(2078 µg/kg) was also detected in a Swedish wheat [17,31,32,41].
The prevalence of MON in feed was high, namely 76–79%, as reported by Kovalsky et al. and
Streit et al. (2013). In contrast, only 3% of the Brazilian poultry feed samples was contaminated with
MON. Reported maximum concentration from worldwide feed samples was 12,236 µg/kg. [4,39,40].
3.2. Toxicity of onilifor in
The in vitro and in vivo toxic effects of are su arized in Tables 2 and 3, respectively.
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Table 3. In vivo toxicity of moniliformin and Alternaria mycotoxins.
Animal Species Mycotoxin Route of Exposure Exposure Time Exposure Dose Effect Reference
mouse MON po-ip 1x LD50: 20.9 (
♀) 29.1 (♂) mg/kg bw (ip),
survivors clinically healthy [13,92]
TeA iv-po 1x 0–398 mg/kg bw LD50: 76–162 (iv) and 81–209 (po),vomiting, diarrhea, hemorrhages, death
Sprague-Dawley rats MON po 1x 5 mg/kg bw no clinical signs [13,98,99]
1x 10 mg/kg bw
↓ activity for 24 h, respiratory changes,
trembling, piloerection, complete
recovery within 48 h
1x 25–50 mg/kg bw
respiratory and cardiovascular changes,
collapse, convulsion and death within
48–83 min
28 days 3–6 mg/kg bw
no clinical symptoms, no effect on
leucocyte and red blood cell counts,
food and water consumption or organ
and body weights, ↓ phagocytic activity
of neutrophils
TeA iv-po 1x 0–398 mg/kg bw
LD50: 83–157 (iv) and LD50: 168–240
(po), vomiting, diarrhea, hemorrhages,
death
Syrian golden
hamster AME ip 1x 200 mg/kg bw
severe necrosis and coalescence of
visceral organs
lethargy, breathing difficulties, flaccid
hind limbs↑ resorptions and ↓ fetal
weight
[100]
chicken embryo MON injection 1x LD50: 2.8 µg/egg, no gross teratogeniceffects in survivors [92]
TeA injection 1x 150–1500 µg/egg dose-related mortality, LD50:548 µg/egg [101]
1-day old chicken MON po 1x 0–16 mg/kg bw LD50: 5.4 mg/kg bw (crop intubation),survivors clinically healthy [92]
broiler chickens MON feed 21 days 200 mg/kg feed
death (56%)
↑ kidney, heart and liver weight
↑ serum albumin, total protein and
aspartate aminotransferase
[11,14,102]
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Table 3. Cont.
Animal Species Mycotoxin Route of Exposure Exposure Time Exposure Dose Effect Reference
100 mg/kg feed
↓ feed intake and body weight gain
↑ hearth weight
↑ kidney weight if feed also contained
200 mg FB1/kg
↑ incidence of large pleomorphic
cardiomyocyte nuclei
loss of cardiomyocyte cross striations
mild focal renal tubular mineralization
feed 42 days (day 7–49) 50 mg/kg feed
mortality (13.3%)
↑ feed consumption, ↓ body weight gain,
↓ feed conversion
↑ relative heart and proventriculus
weight, ↓mean corpuscular volume
↑ serum gamma glutamyltransferase
activity
loss of cardiomyocyte cross striations
↑ cardiomyocyte nuclear size
25 mg/kg feed
mortality (7.8%)
↑ serum gamma glutamyltransferase
activity
TeA po 21 days 1.25–2.5 mg/kg bw
↓ weight gain and feed efficiency
hemorrhages, erosions of the gizzard,
pale mottled spleens, edema of the
myocardium, microscopic congestions
of blood vessels and hemorrhages
White leghorn
chicken TeA po 1x
LD50: 37.5 mg/kg bw with hemorrhages
of the musculature of the thigh, breast,
heart and subcutaneous tissues
[14]
21 days 0.63 mg/kg bw
pathological changes in spleen and
gizzard but no extensive hemorrhages
microscopic congestions of blood vessels
and hemorrhages
21 days 1.25–2.5 mg/kg bw
↓ weight gain and feed efficiency
hemorrhages, erosions of the gizzard,
pale mottled spleens, edema of the
myocardium, microscopic congestions
of blood vessels and hemorrhages
turkeys MON feed 91 days (day 7–98) 25, 37.5,50 mg/kg feed ↑ relative heart weight [102]
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Table 3. Cont.
Animal Species Mycotoxin Route of Exposure Exposure Time Exposure Dose Effect Reference
37.5, 50 mg/kg feed ↑ relative liver weight
50 mg/kg feed
loss of cardiomyocyte cross striations
↑ cardiomyocyte nuclear size, ↑ number
of cardiomyocyte mitotic figures
turkey poults MON feed 21–28 days 100 mg/kg feed
↓ feed intake, body weight gain, feed
efficiency, ↓ relative thymus, bursa and
spleen weights,
↓ primary and secondary antibody
response to inactivated Newcastle
disease virus,
↓ systemic clearance of E. coli
[103]
Japanese quail MON feed 35 days 100 mg/kg feed
cardiomegaly, myocardial congestion,
hypertrophy, myocardial disarray, ↑
mitochondria, resulting in separation of
muscle fibers, swollen and deformed
mitochondria with degenerative
changes. Congestion, hemorrhages and
degenerative changes more pronounced
and extensive disruption of muscle
fibers and destruction of Z-bands when
feed contained both MON and
fumonisin B1. Death.
[12]
barrow MON feed 28 days 100 mg/kg feed
acute mortality due to apparent cardiac
failure
↓ body weight gain
↓ body weight gain, feed consumption
and feed efficiency when feed also
contained FB1
[104]
dog TeA iv-po 1x 25–50 mg/kg bw severe tachycardia, massive diffusehemorrhages, (bloody) diarrhea [13]
iv 3x 20 mg/kg bw severe hemorrhagic gastro-enteropathy,death
iv-po 6–30 days 0.0625–11.2 mg/kgbw
salivation, emesis, tachycardia,
hemorrhagic gastro-enteropathy, death
monkey TeA iv 3x 20 mg/kg bw severe hemorrhagic gastro-enteropathy,death [13]
iv-po 7–45 days 11.2–89.6 mg/kg salivation, emesis, hemorrhagicgastro-enteropathy, death
↓ decrease; ↑ increase.
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MON exerts its toxic effects by inactivating thiamine enzymes, including pyruvate dehydrogenase.
Pyruvate dehydrogenase contributes to the formation of acetyl-CoA, which is used in the Krebs cycle.
Consequently, MON compromises cellular energy supply [105].
In vitro half maximal inhibitory concentration (IC50) of MON ranged between 24 and >100 µg/mL
in different cell lines [66]. MON negatively affect immune system by disturbing monocyte
differentiation into dendritic cells and macrophages [53]. Furthermore, MON was clastogenic in
human lymphocytes and caused chromosomal aberrations, an increase in sister chromatid exchanges
and an increase in micronuclei frequency in a dose-dependent manner [8] (Table 2).
MON is strikingly toxic in vivo (Table 3). The heart is the main target organ of MON, causing acute
heart failure, but the mycotoxin can also cause muscle weakness, respiratory distress and negatively
affect immunity and animal performance [11,12,98,103,104]. MON is acutely toxic and has a narrow
range of toxicity with an LD50 cut-off value of 25 mg/kg bw in rats. Similarly, 56% of the broiler
chickens fed a diet contaminated with 200 mg MON/kg feed died. Assuming that broilers have a
daily feed consumption of 100 g feed/kg bw, the LD50 in poultry and rats is similar [11,98]. A 28-day
subacute toxicity study demonstrated that low oral doses of MON (3–6 mg/kg bw) did not cause
clinical symptoms in rats. Higher doses caused somnolence and muscle weakness. Two animals in the
highest dose group died of acute heart failure. The phagocytic activity of neutrophils was decreased in
all treatment groups (3–15 mg/kg bw) even up to 14 days after the last administration, suggesting
a prolonged inhibiting effect of MON on the innate immune system [99]. In poultry, chronic dietary
exposure to MON negatively influenced the immune response and performance. Cardiotoxicity and
hepatotoxicity of MON have been observed in turkeys at contamination levels of 25 mg/kg and
37.5 mg/kg feed, respectively. Higher mortality rates, lower feed conversion rates, higher heart and
proventriculus weights and heart lesions were observed in broilers fed a MON contaminated diet
of 50 mg MON/kg feed [102,103]. Similarly, Japanese quails fed a diet containing MON suffered
from cardiac lesions (Table 3). When the feed was co-contaminated with fumonisin B1, more severe
lesions were observed. Interestingly, a massive increased number of mitochondria was associated
with the disruption of heart muscle fibers. This increase of the number of mitochondria could be a
compensatory event for the decreased cellular energy, since MON compromises the Krebs cycle [12,105].
It should be noted that the experimental MON levels in the feed studies were about a factor 1000
higher (50–200 mg/kg) than the levels usually found in feed samples (µg/kg range). However, high
contamination levels (up to 12 mg/kg), approaching the hepato- and cardiotoxic levels for poultry
(25–50 mg/kg), occasionally occur [4,102].
3.3. Toxicokinetics of Moniliformin
The toxicokinetic behavior of MON is largely unknown. MON did not affect intestinal nor blood
capillary integrity in vitro. However, in vitro studies suggest that the molecule can pass the blood
brain barrier [59,106]. After single oral gavage, 42% of the administered MON was excreted in the
urine of rats within 24 h post administration, and less than 1% was excreted in the feces. No other
toxicokinetic data were reported in this study [98]. To the best of the authors’ knowledge, no residue
studies of MON in animal-derived products have been described.
4. Alternaria Mycotoxins
Alternaria fungi contaminate a wide variety of food and feed crops and produce several toxins,
with AOH, AME, TeA, altenuene (ALT) and altertoxins (ATXs) being the most important ones [2].
A. alternata and A. arborescens species produce TeA, ALT, AOH and AME. Besides, A. alternata also
produces stemphyltoxin III (STTX-III) [107,108]. Furthermore, TeA is also produced by A. bertholletius,
A. caelatus, A. nominus, A. pseudonominus, A. arachidicola and A. bombycis [109]. Their chemical structure
is presented in Figure 3.
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4.1. Oc ur ence of Alternaria Mycotoxins
Contamination of fo d and fe d samples with Alternaria mycotoxins is ubiquitous in grains,
fruits, vegetables and wines, as summarized in Table 1. Especially TeA is omnipresent in dried figs,
sunflower se ds and tomato products [18,19,36,42,46–48]. Grain samples (wheat, maize and cereals)
were most frequently contaminated with TeA (15–10 %), followed by TEN (7 %), AOH (2.4–31%),
AME (3–26%), ALT (2.6–7%) and ATX-I (2.4%). For most Alternaria mycotoxins, contamination levels
in grains were <10 µg/kg and aximum concentrations were <10 µg/kg. o ever, the maximum
observed TeA contamination level in wheat was 42 4 µg/kg [36,42–45]. The majority of sunflower
se ds, collected in retail stores in the Netherlands in 2013–2014, were contaminated with TeA with
maximum concentrations f µ kg. TEN contaminated 20–91% (maximum concentration of
0.8 mg/kg), while AOH and AME w re found in 10–64% of the s fl t lo concentrations
(<50 µg/ ). It l te t at the total nu ber of samples was limited to 15 [46,47]. Although
no Alternaria toxins were found in fresh tomatoes, most tomato products were contaminated with at
least one Alternaria mycotoxin. TeA was detected in all tomato concentrates and almost all tomato
sauces (78–10 %), pastes (80%) and juices (50–10 %). Furthermore, about half of the tomato pieces
(60%) and ketchup (40%) samples were positive for TeA. Th maximum TeA levels in tomato products
ranged between 100 and 462 µg/kg. AOH (28–86%), AME (20–78%) and TEN (21–64%) were also
frequently detected in tomato products, b t contamination levels w r usually a low as a few µg/kg.
Plants can metabolis mycotoxins, f rming toxi s c njugated with sulphates or suga moieties. Th
conjugated m tabolites, AOH-3-sulfate and AME-3-sulfate, were found in tomat juices, sauce and
co centrates in concentrations up to 10 µg/kg. Glucoside of AOH and AME were not detected in
figs, sunflower or t mato products [18,19,46,47]. Besides, most Alternaria toxins were also detected in
fruit j ices and wines. Contamination lev ls were us ally a few µg/L. TeA was found in the highest
concentrations, na ely µ L in juices, 60 µg/L in white and 46 µg/L in red wi e. In contrast,
ATX-I and ATX-II were not detected in bakery products, wines, juices or vegetable oils. However,
the number of samples was limited, which could be a bias l i i t s f less frequently
occurring toxins [18,19,48]. Noteworthy, all infant fo d products were contaminated with TeA with
levels ranging betwe n 0.8–1,20 µg/kg. ighest conta ination levels were found in sorghum-based
infant cereals (mean 5 0 µg/kg) [49].
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Similar to food samples, the prevalence of Alternaria mycotoxins in feed samples varies
enormously with contamination levels between 0–80% for AOH and 1.5–82% for AME. Maximum
levels were 221 µg/kg and 733 µg/kg for AOH and AME, respectively. Sixty-five percent of feed
samples were contaminated with TeA up to 1983 µg/kg [4,50,51].
4.2. Toxicity of Alternaria Mycotoxins
The toxicity data of Alternaria toxins are summarized in Tables 2 and 3. AOH and AME are
cytotoxic and induce apoptotic cell death through the mitochondrial pathway [67–69]. Recently,
the mechanisms of AOH toxicity were reviewed by Solhaug et al. (2016) [110]. AOH forms ROS
and interacts with DNA topoisomerase, causing single and double DNA strand breaks. Cell cycle
arrest in G2/M-phase, possibly in an attempt to repair the DNA damage, causes a decrease in
proliferation. Similarly, AME is also mutagenic and causes DNA strand breaks and cell cycle
arrest [9,10,55,67,68,110,111]. The quinones ATX-II and STTX-III are much stronger mutagens
compared to AOH [9,10]. Under cell free conditions, ATX-II, STTX-III and AOH inhibit topoisomerase
IIα. While AOH acts as a topoisomerase poison, ATX-II and STTX-III are catalytic inhibitors. AOH, but
not ATX-II and STTX-III, causes double DNA strand breaks. It is suggested that ATX-II and STTX-III
induce DNA damage through the formation of adducts via epoxide groups [10].
Moreover, AOH acts immunomodulating in THP-1 monocytes by interfering with macrophage
differentiation and decreasing TNF-α secretion. AOH induced morphological changes and modified
the phenotype in both RAW 264.7 mouse and primary human macrophages. Endocytic activity
and autophagy were increased in RAW 264.7, but decreased in primary human macrophages.
Furthermore, RAW 264.7 macrophages entered senescence following prolonged exposure to AOH
(48–72 h, 30–60 µM) [55,75,110,112].
The dibenzo-α-pyrones AOH, AME and ALT structurally resemble estradiol. AOH exhibits
an estrogenic response and interferes with steroidogenesis [70,72,73]. Progesterone and estradiol
levels and progesterone receptor expression were increased by the estrogenic action of AOH in
human adrenocortical carcinoma cells and transformed human mammary gland cells [72]. In contrast,
progesterone secretion and cell viability were negatively affected by both AOH and AME, but not TeA
in porcine granulosa cells. Furthermore, AOH and AME decreased the abundance of the key enzyme
in progesterone synthesis, i.e. P450 cholesterol side-chain cleavage enzyme (P450SCC), but not the
corresponding gene transcript (Cyp11a1) [71]. In vivo studies on the effects of Alternaria mycotoxins
on reproductive and developmental health are limited. AME (200 mg/kg bw, ip) was maternally
toxic and fetotoxic to Syrian golden hamsters, but did not cause teratogenic malformations [100]. In a
chicken embryo assay, AOH, AME and ALT did not cause mortality, difference in weight of hatched
chicks or teratogenic effects at doses up to 1000; 500 and 1000 µg/egg, respectively [101].
TeA exerts its toxic effect through the inhibition of the release of newly formed proteins from the
ribosomes [113]. Although in vitro studies are limited, they suggest a low in vitro toxicity of TeA [114].
However, its in vivo effects are more severe. TeA caused emesis, salivation, tachycardia, hemorrhages
and hemorrhagic gastro-enteropathy in rats, mice, dogs and monkeys. Similarly, hemorrhages were
also observed when feeding broiler chickens and laying hens a diet contaminated with high TeA levels.
Oral LD50 of tenuazonic sodium salt ranged between 81–186 mg/kg bw in mice and rats. In a chicken
embryo assay, the LD50 for TeA was 548 µg/egg, but TeA did not cause teratogenic effects at doses
ranging between 150 and 1500 µg/egg [13,14,101].
In 2011, EFSA published a scientific opinion on the risks for animal and public health related to the
presence of Alternaria toxins in feed and food. A threshold of toxicological concern (TTC) of 2.5 ng/kg
bw/day was established for AOH and AME. Since there is no evidence of genotoxic action, the TTC for
TeA was set at 1500 ng/kg bw/day. The mean and 95th percentile dietary exposure exceeded the TTC
for AOH (factor 16 and 33) and AME (factor 2 and 6), but not for TeA (factor 0.009) [15,18]. Recently,
the exceeding of the TTC for AOH and AME, through the consumption of bakery products, juices
and tomato products has been confirmed for the German and Belgian population [18,19]. However,
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this EFSA opinion could be considered out of date, since more occurrence data are now available.
Especially for TeA, the number of left censored data is decreased and the prevalence of this mycotoxin
is high in a variety of food products like wine, figs, grain and tomato products (Table 1). In accordance
with the EFSA opinion, both the mean and the 95th percentile dietary exposures via the consumption
of tomato products were recently found to be below the TTC for TeA with a factor of 0.07 and 0.5,
respectively [19]. However, TeA not only contaminates tomato products. A more comprehensive
study including bakery products, juices, tomato products and sunflower seeds resulted in an 95th
percentile dietary exposure exceeding the TTC for TeA, AOH and AME, with a factor 1.4, 12 and
60 respectively [18]. However, it needs to be stressed that for infants the dietary exposure to TeA is
estimated to exceed the TTC with a factor of 2.4 due to the high contamination of sorghum/millet
based cereals [115].
4.3. Toxicokinetics of Alternaria Mycotoxins
Fraeyman et al. (2015) demonstrated the complete oral bioavailability of TeA in both pigs and
broiler chickens. Furthermore, the total body Cl of TeA in pigs (0.45 L/h/kg) and broiler chickens
(0.06 L/h/kg) was rather low. The low Vd in both broiler chickens (0.2 L/kg) and pigs (0.3 L/kg)
could indicate a limited tissue distribution. However, especially in broiler chickens, the low Cl could
possibly result in accumulation of TeA when animals are regularly fed a contaminated diet, possibly
compromising animal health and elevating the risk for carry-over into the food chain. Therefore, tissue
residue studies are recommended [22]. Likewise, the oral bioavailability of TeA is probably also high
in humans, since almost 90% of the ingested dose was recovered in the urine of two volunteers [116].
In contrast, a recent kinetic study in mice suggests a low systemic absorption of AOH, since 90% of the
total dose was excreted via the feces and up to 9% via the urine [117].
To the best of the authors’ knowledge, no data is available regarding carry-over of Alternaria
mycotoxins into animal derived products. However, Asam et al. (2013) demonstrated the exposure
of humans to TeA through the consumption of animal-derived products, since human urine tested
positive for TeA, when the diet was restricted to cheese, milk and milk products [116].
5. Research Gaps
Taken together, contamination levels of these emerging Fusarium and Alternaria mycotoxins
are usually low (µg/kg range). However, higher contamination levels of enniatins and tenuazonic
acid may occasionally occur. In vitro studies suggest genotoxic effects of enniatins A, A1 and B1,
beauvericin, moniliformin, alternariol, alternariol monomethyl ether, altertoxins and stemphyltoxin-III.
Furthermore, in vitro studies suggest immunomodulating effects of most emerging toxins and a
reproductive health hazard of alternariol, beauvericin and enniatin B.
As can be concluded from this literature review, there are still remaining knowledge gaps
regarding the studied emerging Fusarium and Alternaria toxins in all three key factors for a proper risk
assessment, including occurrence, toxicity and toxicokinetic data. Concerning the occurrence data,
especially data on emerging toxins in animal-derived products and conjugated Alternaria mycotoxins in
different food samples is lacking. An evaluation of the carcinogenic risk of the emerging Fusarium and
Alternaria mycotoxins for humans by IARC is advisable. Furthermore, effects on reproductive health
and immune system demonstrated in in vitro studies should be verified in vivo. Special attention
should be paid to the combinatory effects of emerging mycotoxins and other immunomodulating (e.g.,
DON or pathogens) and estrogenic (e.g., ZEN or phytoestrogens) substances. Besides, toxicokinetic
studies on MON are lacking and toxicokinetics of ENNs, BEA, AOH, AME and TeA are too limited to
estimate tissue residues. Therefore, there is a gap between the in vitro toxicity data and the in vivo
effect of these mycotoxins. Taking into account new occurrence data for TeA, especially in infant food,
the complete oral bioavailability and low total body Cl in animals and the limited toxicity data, a
health risk cannot be completely excluded. Above, several studies indicate a dietary exposure above
the TTC of 1500 ng/kg bw/day [15,18,115]. Therefore, a new risk evaluation, including vulnerable
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populations by EFSA may be considered. Besides, the cardiotoxic MON and the possible genotoxic
compounds ATXs and STTX-III may be added to the risk evaluation.
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